EULAR recommendations for the management of large vessel vasculitis

C. Mukhtyar; L. Guillevin; M. C. Cid; B. Dasgupta; K. de Groot; W. Gross; T. Hauser; B. Hellmich; D. Jayne; C. G. M. Kallenberg; P. A. Merkel; H. Raspe; C. Salvarani; D. G. I. Scott; C. Stegeman; R. A. Watts; K. Westman; J. Witter; H. Yazici; R. Luqmani; European Vasculitis Study Group

doi:10.1136/ard.2008.088096

EULAR recommendations for the management of large vessel vasculitis

C. Mukhtyar, L. Guillevin, M. C. Cid, B. Dasgupta, K. de Groot, W. Gross, T. Hauser, B. Hellmich, D. Jayne, C. G. M. Kallenberg, P. A. Merkel, H. Raspe, C. Salvarani, D. G. I. Scott, C. Stegeman, R. A. Watts, K. Westman, J. Witter, H. Yazici, R. LuqmaniEuropean Vasculitis Study Group

Research output: Contribution to journal › Article

795 Citations (Scopus)

Abstract

Objectives: To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis.

Methods: An expert group (consisting of 10 rheumatologists, 3 nephrologists, 2 immunologists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search using a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of small and medium vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion.

Results: In all, 15 recommendations were made for the management of small and medium vessel vasculitis. The strength of recommendations was restricted by low quality of evidence and by EULAR standardised operating procedures.

Conclusions: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.

Original language	English
Pages (from-to)	318-323
Number of pages	6
Journal	Annals of the Rheumatic Diseases
Volume	68
Issue number	3
DOIs	https://doi.org/10.1136/ard.2008.088096
Publication status	Published - Aug 2009

Access to Document

10.1136/ard.2008.088096

Cite this

Mukhtyar, C., Guillevin, L., Cid, M. C., Dasgupta, B., de Groot, K., Gross, W., Hauser, T., Hellmich, B., Jayne, D., Kallenberg, C. G. M., Merkel, P. A., Raspe, H., Salvarani, C., Scott, D. G. I., Stegeman, C., Watts, R. A., Westman, K., Witter, J., Yazici, H., ... European Vasculitis Study Group (2009). EULAR recommendations for the management of large vessel vasculitis. Annals of the Rheumatic Diseases, 68(3), 318-323. https://doi.org/10.1136/ard.2008.088096

@article{3b468669728b49129fe0de0efedd4608,

title = "EULAR recommendations for the management of large vessel vasculitis",

abstract = "Objectives: To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. Methods: An expert group (consisting of 10 rheumatologists, 3 nephrologists, 2 immunologists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search using a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of small and medium vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion. Results: In all, 15 recommendations were made for the management of small and medium vessel vasculitis. The strength of recommendations was restricted by low quality of evidence and by EULAR standardised operating procedures. Conclusions: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.",

author = "C. Mukhtyar and L. Guillevin and Cid, {M. C.} and B. Dasgupta and {de Groot}, K. and W. Gross and T. Hauser and B. Hellmich and D. Jayne and Kallenberg, {C. G. M.} and Merkel, {P. A.} and H. Raspe and C. Salvarani and Scott, {D. G. I.} and C. Stegeman and Watts, {R. A.} and K. Westman and J. Witter and H. Yazici and R. Luqmani and {European Vasculitis Study Group}",

year = "2009",

month = aug,

doi = "10.1136/ard.2008.088096",

language = "English",

volume = "68",

pages = "318--323",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "3",

}

Mukhtyar, C, Guillevin, L, Cid, MC, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, CGM, Merkel, PA, Raspe, H, Salvarani, C, Scott, DGI, Stegeman, C, Watts, RA, Westman, K, Witter, J, Yazici, H, Luqmani, R & European Vasculitis Study Group 2009, 'EULAR recommendations for the management of large vessel vasculitis', Annals of the Rheumatic Diseases, vol. 68, no. 3, pp. 318-323. https://doi.org/10.1136/ard.2008.088096

TY - JOUR

T1 - EULAR recommendations for the management of large vessel vasculitis

AU - Mukhtyar, C.

AU - Guillevin, L.

AU - Cid, M. C.

AU - Dasgupta, B.

AU - de Groot, K.

AU - Gross, W.

AU - Hauser, T.

AU - Hellmich, B.

AU - Jayne, D.

AU - Kallenberg, C. G. M.

AU - Merkel, P. A.

AU - Raspe, H.

AU - Salvarani, C.

AU - Scott, D. G. I.

AU - Stegeman, C.

AU - Watts, R. A.

AU - Westman, K.

AU - Witter, J.

AU - Yazici, H.

AU - Luqmani, R.

AU - European Vasculitis Study Group

PY - 2009/8

Y1 - 2009/8

N2 - Objectives: To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. Methods: An expert group (consisting of 10 rheumatologists, 3 nephrologists, 2 immunologists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search using a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of small and medium vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion. Results: In all, 15 recommendations were made for the management of small and medium vessel vasculitis. The strength of recommendations was restricted by low quality of evidence and by EULAR standardised operating procedures. Conclusions: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.

AB - Objectives: To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. Methods: An expert group (consisting of 10 rheumatologists, 3 nephrologists, 2 immunologists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search using a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of small and medium vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion. Results: In all, 15 recommendations were made for the management of small and medium vessel vasculitis. The strength of recommendations was restricted by low quality of evidence and by EULAR standardised operating procedures. Conclusions: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.

U2 - 10.1136/ard.2008.088096

DO - 10.1136/ard.2008.088096

M3 - Article

VL - 68

SP - 318

EP - 323

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 3

ER -